Published in Psychopharmacology (Berl) on December 01, 1994
Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress (2009) 1.61
Chirality and drugs used in psychiatry: nice to know or need to know? Cell Mol Neurobiol (1999) 0.92
Influence of a chronic ultramild stress procedure on decision-making in mice. J Psychiatry Neurosci (2000) 0.83
Experimental psychiatric illness and drug abuse models: from human to animal, an overview. Methods Mol Biol (2012) 0.82
The chronic mild stress (CMS) model of depression: History, evaluation and usage. Neurobiol Stress (2016) 0.80
Simulating the anhedonia symptom of depression in animals. Dialogues Clin Neurosci (2002) 0.76
Repeated social defeat stress enhances the anxiogenic effect of bright light on operant reward-seeking behavior in rats. Behav Brain Res (2015) 0.75
The validity of animal models of depression. Psychopharmacology (Berl) (1984) 2.07
An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) (1991) 1.61
Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol Behav (1994) 1.40
Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology (Berl) (1995) 1.36
Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology (Berl) (1992) 1.28
A comparison of two alcohol craving questionnaires. Addiction (1998) 1.27
Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berl) (1994) 1.17
Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev (1992) 1.14
Smoking-related cues elicit craving in tobacco "chippers": a replication and validation of the two-factor structure of the Questionnaire of Smoking Urges. Psychopharmacology (Berl) (2000) 1.14
Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol (1996) 1.09
Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog Neuropsychopharmacol Biol Psychiatry (1986) 1.06
Patterns of alcohol, cigarette and illicit drug use in English adolescents. Addiction (1998) 1.05
Antidepressant-like effects of dopamine agonists in an animal model of depression. Biol Psychiatry (1992) 1.04
The Questionnaire of Smoking Urges is sensitive to abstinence and exposure to smoking-related cues. Behav Pharmacol (1999) 1.03
Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res (1983) 1.02
Changes in sleep architecture following chronic mild stress. Biol Psychiatry (1997) 1.00
Real time measurement of stimulated dopamine release in the conscious rat using fast cyclic voltammetry: dopamine release is not observed during intracranial self stimulation. J Neurosci Methods (1998) 0.99
Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment. Behav Pharmacol (1997) 0.96
Dopamine and depression: a review of recent evidence. II. Theoretical approaches. Brain Res (1983) 0.95
Diurnal variation in the effect of chronic mild stress on sucrose intake and preference. Physiol Behav (1997) 0.91
Clonidine induced intrahypothalamic stimulation of eating in rats. Psychopharmacologia (1972) 0.91
Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments. Brain Res (1983) 0.91
Effects of dopamine receptor antagonists on sucrose consumption and preference. Psychopharmacology (Berl) (1989) 0.90
Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant. Eur J Pharmacol (1997) 0.88
Parametric analysis of the effects of cocaine and cocaine pretreatment on dopamine release in the nucleus accumbens measured by fast cyclic voltammetry. Brain Res (1995) 0.88
Deprivation state but not nicotine content of the cigarette affects responding by smokers on a progressive ratio task. Psychopharmacology (Berl) (1998) 0.87
Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology (Berl) (1991) 0.87
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials. Pharmacol Biochem Behav (1983) 0.85
Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology (Berl) (1993) 0.83
Behavioural microanalysis of the role of dopamine in amphetamine anorexia. Pharmacol Biochem Behav (1988) 0.83
Antidepressants and serotonergic neurotransmission: an integrative review. Psychopharmacology (Berl) (1985) 0.83
Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine. Psychopharmacology (Berl) (1991) 0.83
A reappraisal of the interaction between tricyclic antidepressants and reserpine-like drugs. Psychopharmacology (Berl) (1978) 0.82
Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology (Berl) (1994) 0.82
Decreased reactivity to sweetness following chronic exposure to mild unpredictable stress or acute administration of pimozide. Neurosci Biobehav Rev (1992) 0.81
Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress. J Psychopharmacol (1992) 0.81
Effects of pimozide on sucrose consumption and preference. Psychopharmacology (Berl) (1987) 0.81
Sweetness-dependent facilitation of sucrose drinking by raclopride is unrelated to calorie content. Pharmacol Biochem Behav (1991) 0.80
Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress. Behav Pharmacol (1997) 0.80
Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology (Berl) (1992) 0.80
8-OH-DPAT-induced place preference and place aversion: effects of PCPA and dopamine antagonists. Psychopharmacology (Berl) (1991) 0.80
Changes in dopamine autoreceptor sensitivity in an animal model of depression. Psychopharmacology (Berl) (1988) 0.79
Time-, schedule-, and reinforcer-dependent effects of pimozide and amphetamine. Psychopharmacology (Berl) (1991) 0.79
Multiple variable interval schedule behaviour in humans: effects of ethanol, mood, and reinforcer size on responding maintained by monetary reinforcement. Behav Pharmacol (1998) 0.79
Suppression or facilitation of operant behaviour by raclopride dependent on concentration of sucrose reward. Psychopharmacology (Berl) (1991) 0.79
Dopaminergic mechanism of imipramine action in an animal model of depression. Biol Psychiatry (1990) 0.79
Reward-dependent suppression or facilitation of consummatory behaviour by raclopride. Psychopharmacology (Berl) (1991) 0.78
Conditioned taste aversion and conditioned drinking: two independent and opposing effects of 5-hydroxytryptophan? Psychopharmacology (Berl) (1986) 0.78
Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. Psychopharmacology (Berl) (1993) 0.78
Cognitive functioning in depression: a review of theory and research. Psychol Med (1984) 0.78
Effects of chlordiazepoxide and sodium valproate in two tests of spatial behaviour. Pharmacol Biochem Behav (1986) 0.78
Social influences on morphine conditioned place preference. Behav Pharmacol (1997) 0.77
Brief exposure to uncontrollable but not to controllable noise biases the retrieval of information from memory. Br J Clin Psychol (1986) 0.77
Behavioural changes during withdrawal from desmethylimipramine (DMI). II. Increased resistance to extinction. Psychopharmacology (Berl) (1981) 0.77
Motivation for alcohol assessed by multiple variable interval schedule behaviour: effects of reward size and alcohol cues. Behav Pharmacol (2001) 0.77
Behavioural changes during withdrawal from desmethylimipramine (DMI). I. Interactions with amphetamine. Psychopharmacology (Berl) (1981) 0.77
Apomorphine anorexia: the role of dopamine receptors in the ventral forebrain. Psychopharmacology (Berl) (1988) 0.76
Apomorphine anorexia: a behavioural and neuropharmacological analysis. Psychopharmacology (Berl) (1985) 0.76
Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists. Psychopharmacology (Berl) (1989) 0.75
Behavioural specificity of 8-OH-DPAT-induced feeding. Psychopharmacology (Berl) (1988) 0.75
Influence of nicotine gum on acute cravings for cigarettes. J Psychopharmacol (2004) 0.75
'It's made all of us bond since that course…' - a qualitative study of service users' experiences of a CBT anger management group intervention. J Intellect Disabil Res (2014) 0.75
Cognitive behavioural anger management intervention for people with intellectual disabilities: costs of intervention and impact on health and social care resource use. J Intellect Disabil Res (2014) 0.75
Osgood-Schlatter's disease: etiology and treatment. Clin Orthop Relat Res (1969) 0.75
Similar effects of chronic unpredictable mild stress and chronic imipramine administration on release of mesolimbic dopamine. J Psychopharmacol (1992) 0.75
Microstructural analysis of the involvement of beta-receptors in amphetamine anorexia. Pharmacol Biochem Behav (1982) 0.75
Eight-year experience in treatment of hemorrhoidal disease. Acta Chir Hung (1998) 0.75
Changes in amphetamine-induced anorexia and stereotypy during chronic treatment with antidepressant drugs. Eur J Pharmacol (1984) 0.75
Apomorphine anorexia: the role of dopamine cell body autoreceptors. Psychopharmacology (Berl) (1986) 0.75
Recurrent dislocation of the patella. Clin Orthop Relat Res (1970) 0.75
Subchronic treatment with the tricyclic antidepressant DMI increases isolation-induced fighting in rats. Pharmacol Biochem Behav (1981) 0.75
A conceptual framework for psychobiological synthesis. Biol Psychiatry (1983) 0.75
Central and peripheral contributions to the enhancement of amphetamine anorexia by desmethylimipramine (DMI). Pharmacol Biochem Behav (1985) 0.75
The ability of antidepressant drugs to desensitize beta-receptors is inversely correlated with their clinical potency. J Affect Disord (1984) 0.75
Drugs, biochemistry, and conscious experience: toward a theory of psychopharmacology. Perspect Biol Med (1984) 0.75
The relevance of problems and models to treatment outcome: a comparative study of two agencies. Subst Use Misuse (1999) 0.75
Changes in thought content following sleep deprivation in depression. Compr Psychiatry (1984) 0.75
Specific disruption of spatial behaviour in rats by central muscarinic receptor blockade. Psychopharmacology (Berl) (1986) 0.75
Noradrenergic receptor interactions in feeding elicited by stimulation of the para-ventricular hypothalamus. Pharmacol Biochem Behav (1989) 0.75
Effects of subchronic desmethylimipramine (DMI) treatment on the classically conditioned eyeblink response in rabbits. Commun Psychopharmacol (1980) 0.75
Attenuation of amphetamine anorexia in rats following subchronic treatment with a tricyclic antidepressant. Commun Psychopharmacol (1980) 0.75
Effects of the 5-HT uptake inhibitors, femoxetine and paroxetine, and a 5-HT1A/B agonist, eltoprazine, on the behavioural satiety sequence. Pharmacol Biochem Behav (1992) 0.75
A novel procedure for dissociating the anatomical bases of the behavioral effects of amphetamine. Pharmacol Biochem Behav (1987) 0.75
Cavernous transformation of the portal vein causing jaundice, presenting in the form of Wilson's disease. Acta Chir Belg (2004) 0.75
Fenfluramine disrupts the behavioural satiety sequence in rats. Psychopharmacology (Berl) (1988) 0.75
Apomorphine anorexia: a further pharmacological characterization. Eur J Pharmacol (1986) 0.75
Additive effects of chronic treatment with antidepressant drugs and intermittent treatment with a dopamine agonist. Eur Neuropsychopharmacol (1992) 0.75
Subsensitivity to dopamine agonists following chronic unpredictable mild stress. J Psychopharmacol (1992) 0.75
Pancreatic injury from blunt abdominal trauma in childhood. Acta Chir Belg (2005) 0.75
Practical aspects of a visual aid to decision making. J Intellect Disabil Res (2011) 0.75
Dopamine autoreceptors in the ventral tegmental area show subsensitivity following withdrawal from chronic antidepressant drug treatment. Psychopharmacology (Berl) (1986) 0.75
The behavioural pharmacology of anxiety and depression. Behav Pharmacol (1997) 0.75
Evidence suggesting that DMI-induced resistance to extinction is not mediated by the dorsal noradrenergic bundle. Brain Res (1982) 0.75
Human behavioural pharmacology. Behav Pharmacol (1998) 0.75